HERON THERAPEUTICS, INC. /DE/ (HRTX) Form 8-K — Jun 25, 2026
Heron Therapeutics received a notice from Nasdaq stating that its common stock failed to meet the minimum $1.00 bid price requirement for 30 consecutive trading days. The company has 180 calendar days, or until December 22, 2026, to regain compliance. To cure the deficiency, the closing bid price must be at least $1.00 for a minimum of ten consecutive business days. The notice does not immediately affect the listing or trading of the common stock on the Nasdaq Capital Market.
Key figures
- Compliance Deadline
- December 22, 2026
- Days Below Threshold
- 30 consecutive trading days
- Bid Price Requirement
- $1.00
- Compliance Period Days
- 180
Price after filing
Close on the filing date to close N calendar days later (from $0.41). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.